2,083
Views
37
CrossRef citations to date
0
Altmetric
Review

The applications of metabolomics in the molecular diagnostics of cancer

, , , , , , , ORCID Icon, , & show all
Pages 785-793 | Received 17 Feb 2019, Accepted 13 Aug 2019, Published online: 21 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

María Gallardo-Gómez, Loretta De Chiara, Paula Álvarez-Chaver & Joaquin Cubiella. (2021) Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method. Expert Review of Anticancer Therapy 21:7, pages 723-738.
Read now
Oxana P. Trifonova, Dmitri L. Maslov, Elena E. Balashova & Petr G. Lokhov. (2021) Mass spectrometry-based metabolomics diagnostics – myth or reality?. Expert Review of Proteomics 18:1, pages 7-12.
Read now

Articles from other publishers (35)

Chau-Ming Kan, Xiao Meng Pei, Martin Ho Yin Yeung, Nana Jin, Simon Siu Man Ng, Hin Fung Tsang, William Chi Shing Cho, Aldrin Kay-Yuen Yim, Allen Chi-Shing Yu & Sze Chuen Cesar Wong. (2023) Exploring the Role of Circulating Cell-Free RNA in the Development of Colorectal Cancer. International Journal of Molecular Sciences 24:13, pages 11026.
Crossref
Jingying Gao & Yan Xiao. (2023) Metabolomics and its applications in assisted reproductive technology. IET Nanobiotechnology 17:5, pages 399-405.
Crossref
Wenze Wu, Qingqi Meng, Yan Mi, Feng Wang, Rui Zhang, Wei Li, Dong Liang, Xue-mei Qin & Yue Hou. (2023) A Novel Strategy for the Development of Functional Foods to Improve Energy Metabolism Disorders: Stable Isotope-Resolved Metabolomics. Food and Bioprocess Technology.
Crossref
Wen Li, Yang Li, Zhuo Chen, Alfred King‐yin Lam, Zeping Li, Xiaoling Liu, Baoyu Zhu & Bin Qiao. (2022) Analysis of metabolomics and transcriptomics data in head and neck squamous cell carcinoma. Oral Diseases 29:4, pages 1464-1479.
Crossref
Yu Jin, Shuoqing Fan, Wenna Jiang, Jingya Zhang, Lexin Yang, Jiawei Xiao, Haohua An & Li Ren. (2022) Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus non‐TNBC. PROTEOMICS – Clinical Applications 17:3.
Crossref
Jiaying Yu, Jinhui Zhao, Tongshu Yang, Rennan Feng & Liyan Liu. (2023) Metabolomics Reveals Novel Serum Metabolic Signatures in Gastric Cancer by a Mass Spectrometry Platform. Journal of Proteome Research 22:3, pages 706-717.
Crossref
Hua Zhong, Shuai Liu, Jingjing Zhu & Lang Wu. (2023) Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk. International Journal of Cancer.
Crossref
S.P. Zaletok, O.O. Klenov, V.V. Bentrad, M.P. Prylutskyi, Yu.V. Yanish, Yu.V. Vitruk & E.О. Stakhovsky. (2023) POLYAMINES IN PROSTATE CANCER: THE RELATIONSHIP WITH THE AGGRESSIVENESS OF TUMORS AND THE RISK OF DISEASE PROGRESSION. Oncology 25:2, pages 128-138.
Crossref
Yixun Zhang, Wenjie Xie, Jundong Lin, Yangjia Zhuo, Zhihao Zou, Huichan He, Qianfeng Xu, Zhenfeng Tang, Huijing Tan, Ren Liu, Yulin Deng, Shanghua Cai, Jianheng Ye, Lude Wang, Fen Zou & Weide Zhong. (2022) Untargeted metabolomics to analyze alterations in two-dimensional graphdiyne–copper nanocomposite on the metabolic reprogramming of prostate cancer. 2D Materials 10:1, pages 015011.
Crossref
Yan-Shuang Qi, Man-Yu Xiao, Peng Xie, Jin-Bo Xie, Mei Guo, Fang-Fang Li & Xiang-Lan Piao. (2022) Comprehensive serum metabolomics and network analysis to reveal the mechanism of gypenosides in treating lung cancer and enhancing the pharmacological effects of cisplatin. Frontiers in Pharmacology 13.
Crossref
Krzysztof Ossoliński, Tomasz Ruman, Valérie Copié, Brian P. Tripet, Leonardo B. Nogueira, Katiane O.P.C. Nogueira, Artur Kołodziej, Aneta Płaza-Altamer, Anna Ossolińska, Tadeusz Ossoliński & Joanna Nizioł. (2022) Metabolomic and elemental profiling of blood serum in bladder cancer. Journal of Pharmaceutical Analysis 12:6, pages 889-900.
Crossref
I. V. Druk. (2022) Pancreatic cancer, pancreatogenic diabetes, type 2 diabetes mellitus. Experimental and Clinical Gastroenterology:9, pages 171-182.
Crossref
Yipin Cai, Jie Zhang, Tiantian Xin, Songyuan Xu, Xiaoli Liu, Yu Gao & Haiwei Huang. (2022) Eleutheroside E functions as anti-cervical cancer drug by inhibiting the phosphatidylinositol 3-kinase pathway and reprogramming the metabolic responses. Journal of Pharmacy and Pharmacology 74:9, pages 1251-1260.
Crossref
Eleazer P. Resurreccion & Ka-wing Fong. (2022) The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer. Metabolites 12:6, pages 488.
Crossref
Sabba Mehmood, Muhammad Faheem, Hammad Ismail, Syeda Mehpara Farhat, Mahwish Ali, Sidra Younis & Muhammad Nadeem Asghar. (2022) ‘Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics’. Frontiers in Molecular Biosciences 9.
Crossref
Eleonora Amante, Andrea Cerrato, Eugenio Alladio, Anna Laura Capriotti, Chiara Cavaliere, Federico Marini, Carmela Maria Montone, Susy Piovesana, Aldo Laganà & Marco Vincenti. (2022) Comprehensive biomarker profiles and chemometric filtering of urinary metabolomics for effective discrimination of prostate carcinoma from benign hyperplasia. Scientific Reports 12:1.
Crossref
Olga Golubnitschaja, Peter Kubatka, Alena Mazurakova, Marek Samec, Abdullah Alajati, Frank A. Giordano, Vincenzo Costigliola, Jörg Ellinger & Manuel Ritter. (2022) Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper. Cancers 14:3, pages 675.
Crossref
Nuria Gómez-Cebrián, José Luis Poveda, Antonio Pineda-Lucena & Leonor Puchades-Carrasco. (2022) Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches. Cancers 14:3, pages 596.
Crossref
Mohammad Reza Karimi, Amir Hossein Karimi, Shamsozoha Abolmaali, Mehdi Sadeghi & Ulf Schmitz. (2022) Prospects and challenges of cancer systems medicine: from genes to disease networks. Briefings in Bioinformatics 23:1.
Crossref
Chengnan Fang, Hui Wang, Zhikun Lin, Xinyu Liu, Liwei Dong, Tianyi Jiang, Yexiong Tan, Zhen Ning, Yaorui Ye, Guang Tan & Guowang Xu. (2022) Metabolic Reprogramming and Risk Stratification of Hepatocellular Carcinoma Studied by Using Gas Chromatography–Mass Spectrometry-Based Metabolomics. Cancers 14:1, pages 231.
Crossref
Sonia Perales, Carolina Torres, Cristina Jimenez-Luna, Jose Prados, Joaquina Martinez-Galan, Jose Manuel Sanchez-Manas & Octavio Caba. (2021) Liquid biopsy approach to pancreatic cancer. World Journal of Gastrointestinal Oncology 13:10, pages 1263-1287.
Crossref
Miaomiao Ye, Yibin Lin, Shuya Pan, Zhi-wei Wang & Xueqiong Zhu. (2021) Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis. Frontiers in Oncology 11.
Crossref
Na Li, Weimin Mao, Yun Gao, Ding Wang, Zhengbo Song & Zhongjian Chen. (2021) Liquid chromatography-mass spectrometry based metabolic characterization of pleural effusion in patients with acquired EGFR-TKI resistance. Journal of Pharmaceutical and Biomedical Analysis 202, pages 114147.
Crossref
Benedetta Bendinelli, Alessia Vignoli, Domenico Palli, Melania Assedi, Daniela Ambrogetti, Claudio Luchinat, Saverio Caini, Calogero Saieva, Paola Turano & Giovanna Masala. (2021) Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density. Scientific Reports 11:1.
Crossref
Wei Ye, Yan Lin, Tedros Bezabeh, Changchun Ma, Jiahao Liang, Jiayun Zhao, Ting Ouyang, Wan Tang & Renhua Wu. (2021) 1 H NMR‐based metabolomics of paired esophageal tumor tissues and serum samples identifies specific serum biomarkers for esophageal cancer . NMR in Biomedicine 34:6.
Crossref
Ana Cristina Abreu, Miguel Morales Navas, Cristian Perez Fernández, Fernando Sánchez-Santed & Ignacio Fernández. (2021) NMR-Based Metabolomics Approach to Explore Brain Metabolic Changes Induced by Prenatal Exposure to Autism-Inducing Chemicals. ACS Chemical Biology 16:4, pages 753-765.
Crossref
Ruggero De Maria Marchiano, Gabriele Di Sante, Geny Piro, Carmine Carbone, Giampaolo Tortora, Luca Boldrini, Antonella Pietragalla, Gennaro Daniele, Maria Tredicine, Alfredo Cesario, Vincenzo Valentini, Daniela Gallo, Gabriele Babini, Marika D’Oria & Giovanni Scambia. (2021) Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go. Journal of Personalized Medicine 11:3, pages 216.
Crossref
Beste Turanli, Esra Yildirim, Gizem Gulfidan, Kazim Yalcin Arga & Raghu Sinha. (2021) Current State of “Omics” Biomarkers in Pancreatic Cancer. Journal of Personalized Medicine 11:2, pages 127.
Crossref
Leticia Díaz-Beltrán, Carmen González-Olmedo, Natalia Luque-Caro, Caridad Díaz, Ariadna Martín-Blázquez, Mónica Fernández-Navarro, Ana Laura Ortega-Granados, Fernando Gálvez-Montosa, Francisca Vicente, José Pérez del Palacio & Pedro Sánchez-Rovira. (2021) Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer. Cancers 13:1, pages 147.
Crossref
Hutan Ashrafian, Viknesh Sounderajah, Robert Glen, Timothy Ebbels, Benjamin J. Blaise, Dipak Kalra, Kim Kultima, Ola Spjuth, Leonardo Tenori, Reza M. Salek, Namrata Kale, Kenneth Haug, Daniel Schober, Philippe Rocca-Serra, Claire O’Donovan, Christoph Steinbeck, Isaac Cano, Pedro de Atauri & Marta Cascante. (2021) Metabolomics: The Stethoscope for the Twenty-First Century. Medical Principles and Practice 30:4, pages 301-310.
Crossref
Dawei Yang, Xiaofang Yang, Yang Li, Peige Zhao, Rao Fu, Tianying Ren, Ping Hu, Yaping Wu, Hongjun Yang & Na Guo. (2020) Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal. Journal of Translational Medicine 18:1.
Crossref
Yuechen Liu, Yue Li, Tianpu Zhang, Huan Zhao, Simiao Fan, Xuemeng Cai, Yijia Liu, Zhu Li, Shan Gao, Yubo Li & Chunquan Yu. (2020) Analysis of biomarkers and metabolic pathways in patients with unstable angina based on ultra‑high‑performance liquid chromatography‑quadrupole time‑of‑flight mass spectrometry. Molecular Medicine Reports.
Crossref
Ariadna Martín-Blázquez, Cristina Jiménez-Luna, Caridad Díaz, Joaquina Martínez-Galán, Jose Prados, Francisca Vicente, Consolación Melguizo, Olga Genilloud, José Pérez del Palacio & Octavio Caba. (2020) Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics. Cancers 12:4, pages 1002.
Crossref
Yan Xu, Tianyu Zhao, Haowei Ren, Yindan Xie, Jingjing An, Jiaqi Shang, Dina Tabys & Ning Liu. (2020) Urinary Metabolic Profiling via LC-MS/MS Reveals Impact of Bovine Lactoferrin on Bone Formation in Growing SD Rats. Nutrients 12:4, pages 1116.
Crossref
Yan-Shuang Qi, Man-Yu Xiao, Peng Xie, Jin-Bo Xie, Mei Guo, Fang-Fang Li & Xiang-Lan Piao. (2022) Integrated Network Pharmacology and Serum Metabolomics Analysis to Reveal the Mechanism of Gypenosides Against Lung Cancer and Enhancing Cisplatin Efficiency in Lewis Lung Cancer Mice. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.